Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

The methods tested are reliable for assessing dandruff reduction.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

High-dose androgen therapy can help manage certain types of androgen resistance.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Vitamin D may help reduce severity and relapse of alopecia areata.

Vitamin D Dependent Rickets Type-2A can cause complete hair loss and bone growth issues in infants.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.